Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

He & She MD vs Mint Med

He & She MD
Graded #91

Lower grade

vs+13.200000000000003
Mint Med
Graded #22

Higher grade

The verdict

Mint Med takes it — 84.7/100 to 71.5/100.

Mint Med grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Low both-molecule pricing ($117/$159) and verified — but only 36 states.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueMint Med +36
54
90
Dose & formulationHe & She MD +8
88
80
Clinical oversightMint Med +1
84
85
Labs & monitoringMint Med +21
62
83
FulfillmentHe & She MD +10
92
82
Contract termsMint Med +45
41
86
He & She MD · left barMint Med · right bar

The numbers

MetricHe & She MDMint Med
WeighScore71.5/10084.7/100
GradeCB
Scorecard rank#91#22
Semaglutide$139/mo (starting dose, promotional rate, compounded)$117/mo
Tirzepatide$199/mo (starting dose, compounded)$159/mo
CoverageAll 50 states36 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
He & She MD

Graded #91 · C

Strengths

  • Transparent intro pricing: injectable GLP-1 from $139/month, oral from $199, microdose from $99
  • Compounded semaglutide and tirzepatide (injectable or oral) plus brand access to Ozempic, Wegovy, Zepbound
  • Only charged if medication is prescribed; no hidden fees
  • Free expedited shipping and unlimited board-certified clinician access
  • GLP-1 coaching, nutrition guidance, and in-app progress tracking

Where it loses points

  • Compounded GLP-1s are not FDA-approved finished products (per the site FDA disclaimer)
  • Does not ship to Louisiana or to PO boxes
  • Introductory pricing rises after the 6-month (or 3-month microdose) plan
  • Cash-pay model — insurance billing not indicated
Mint Med

Graded #22 · B

Strengths

  • $117 sema / $159 tirz
  • LegitScript-verified
  • Both molecules

Where it loses points

  • Only 36 states
  • Injection-only
  • Monitoring detail sparse

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard